Understanding how DNA damage affects the replication process in human cells
DNA damage signaling to dormant origins of replication
This study is looking at how our cells start copying their DNA, especially when they're under stress or damage, and it focuses on how certain proteins help manage this process to keep our genetic information safe.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10746122 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which DNA replication is initiated at multiple origins in human chromosomes, particularly under conditions of DNA damage. It focuses on how stress influences the activation of additional replication origins, which are typically dormant. By studying the roles of specific kinases like ATR and Chk1, the research aims to uncover how these proteins regulate the replication process and respond to DNA injury. This could lead to insights into how cells recover from replication stress and maintain genomic stability.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with genetic predispositions to conditions involving DNA damage or replication stress.
Not a fit: Patients with conditions unrelated to DNA damage or those who do not have a genetic component to their disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of DNA repair mechanisms, potentially leading to improved therapies for conditions related to DNA damage.
How similar studies have performed: Other research has shown success in understanding DNA damage responses, but this specific approach to studying dormant origins of replication is relatively novel.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Bakkenist, Christopher J. — University of Pittsburgh at Pittsburgh
- Study coordinator: Bakkenist, Christopher J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.